{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:22:14Z","timestamp":1790716934539,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301597\/2013-8"],"award-info":[{"award-number":["301597\/2013-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305430\/2017-3"],"award-info":[{"award-number":["305430\/2017-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310640\/2017-2"],"award-info":[{"award-number":["310640\/2017-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.09.149","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T22:14:26Z","timestamp":1538432066000},"page":"1170-1180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions"],"prefix":"10.1016","volume":"108","author":[{"given":"Jeronimo N.","family":"Rugani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia F.","family":"Quaresma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia F.","family":"Gontijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo P.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubens L.","family":"Monte-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2018.09.149_bib0005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1994.50.296","article-title":"A general classification of new world Leishmania using numerical zymotaxonomy","volume":"50","author":"Cupolillo","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.149_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061843","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update","volume":"8","author":"Reveiz","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2018.09.149_bib0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1128\/IAI.72.1.508-514.2004","article-title":"Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis","volume":"72","author":"Schriefer","year":"2004","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.biopha.2018.09.149_bib0020","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.trstmh.2009.04.019","article-title":"Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, brazil","volume":"103","author":"Guimaraes","year":"2009","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"12","key":"10.1016\/j.biopha.2018.09.149_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005100","article-title":"Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: clinical, immunological and parasitological aspects","volume":"10","author":"Guimaraes","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.149_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2133.1998.02325.x","article-title":"Unusual clinical variants of cutaneous leishmaniasis in Pakistan","volume":"139","author":"Raja","year":"1998","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.149_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trstmh.2004.02.005","article-title":"Atypical cutaneous leishmaniasis in Central America: possible interaction between infectious and environmental elements","volume":"99","author":"Convit","year":"2005","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.149_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5070\/D385P9D1ST","article-title":"Atypical cutaneous leishmaniasis resembling eczema on the foot","volume":"12","author":"Manzur","year":"2006","journal-title":"Dermatol. Online J."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.149_bib0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0378-6323.19717","article-title":"Chronic zosteriform cutaneous leishmaniasis","volume":"72","author":"Omidian","year":"2006","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"8","key":"10.1016\/j.biopha.2018.09.149_bib0050","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1468-3083.2008.02674.x","article-title":"Atypical presentation of old-world cutaneous leishmaniasis, diagnosis and species identification by PCR","volume":"22","author":"Karamian","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5858\/arpa.2013-0098-OA","article-title":"Comparison of conventional, molecular, and immunohistochemical methods in diagnosis of typical and atypical cutaneous leishmaniasis","volume":"138","author":"Shirian","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molimm.2013.08.008","article-title":"Gene expression profile of cytokines and chemokines in skin lesions from Brazilian Indians with localized cutaneous leishmaniasis","volume":"57","author":"Costa-Silva","year":"2014","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2018.09.149_bib0065","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1517\/17425255.4.9.1209","article-title":"Treatment of leishmaniasis with miltefosine: 2008 status","volume":"4","author":"Berman","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.biopha.2018.09.149_bib0070","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol. Biol. Int."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.149_bib0075","first-page":"378","article-title":"Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children","volume":"55","author":"Apa","year":"2013","journal-title":"Turk. J. Pediatr."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.149_bib0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4269\/ajtmh.12-0736","article-title":"Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama","volume":"89","author":"Sosa","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.149_bib0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","article-title":"Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need","volume":"15","author":"Field","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.149_bib0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2018.09.149_bib0095","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ijantimicag.2007.01.004","article-title":"Leishmania spp.: proficiency of drug-resistant parasites","volume":"29","author":"Natera","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.149_bib0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pt.2016.11.003","article-title":"Exploiting knowledge on leishmania drug resistance to support the quest for new drugs","volume":"33","author":"Hefnawy","year":"2017","journal-title":"Trends Parasitol."},{"issue":"10","key":"10.1016\/j.biopha.2018.09.149_bib0105","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijpara.2007.04.007","article-title":"The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist","volume":"37","author":"Kima","year":"2007","journal-title":"Int. J. Parasitol."},{"issue":"Suppl","key":"10.1016\/j.biopha.2018.09.149_bib0110","first-page":"1","article-title":"The treatment of kala-azar--new approaches to an old problem","volume":"73","author":"Peters","year":"1981","journal-title":"Indian J. Med. Res."},{"issue":"11","key":"10.1016\/j.biopha.2018.09.149_bib0115","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop. Med. Int. Health"},{"issue":"7","key":"10.1016\/j.biopha.2018.09.149_bib0120","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Frezard","year":"2009","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.biopha.2018.09.149_bib0125","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4269\/ajtmh.1997.57.651","article-title":"A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years)","volume":"57","author":"Oliveira-Neto","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3-4","key":"10.1016\/j.biopha.2018.09.149_bib0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species","volume":"64","author":"Palacios","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.biopha.2018.09.149_bib0135","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate","volume":"65","author":"Romero","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0031182010001095","article-title":"Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony","volume":"138","author":"Adaui","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2018.09.149_bib0145","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1038\/cddis.2011.83","article-title":"Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania","volume":"2","author":"Moreira","year":"2011","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.149_bib0150","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1645\/GE-1031R.1","article-title":"Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis","volume":"93","author":"Azeredo-Coutinho","year":"2007","journal-title":"J. Parasitol."},{"key":"10.1016\/j.biopha.2018.09.149_bib0155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.actatropica.2017.05.022","article-title":"Atypical presentations of cutaneous leishmaniasis: a systematic review","volume":"172","author":"Meireles","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.biopha.2018.09.149_bib0160","first-page":"1","article-title":"Distinct genetic profiles of Leishmania (Viannia) braziliensis associate with clinical variations in cutaneous-leishmaniasis patients from an endemic area in Brazil","author":"Quaresma","year":"2018","journal-title":"Parasitology"},{"issue":"5","key":"10.1016\/j.biopha.2018.09.149_bib0165","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1128\/JCM.42.5.2294-2297.2004","article-title":"Culture-independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes","volume":"42","author":"Garcia","year":"2004","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.actatropica.2013.02.002","article-title":"Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil","volume":"126","author":"Torres","year":"2013","journal-title":"Acta Trop."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2307\/3281866","article-title":"Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages","volume":"70","author":"Berman","year":"1984","journal-title":"J. Parasitol."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.149_bib0180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.diagmicrobio.2011.06.011","article-title":"Synthesis, cytotoxicity, and in vitro antileishmanial activity of mono-t-butyloxycarbonyl-protected diamines","volume":"71","author":"Pinheiro","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.09.149_bib0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1475-2875-5-86","article-title":"Dynamics of immune response and drug resistance in malaria infection","volume":"5","author":"Gurarie","year":"2006","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.149_bib0190","first-page":"18","article-title":"Anthelmintics resistance; how to overcome it?","volume":"8","author":"Shalaby","year":"2013","journal-title":"Iran. J. Parasitol."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0195","doi-asserted-by":"crossref","first-page":"e1514","DOI":"10.1371\/journal.pntd.0001514","article-title":"Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background","volume":"6","author":"Decuypere","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2018.09.149_bib0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.actatropica.2016.09.012","article-title":"Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar","volume":"164","author":"Khanra","year":"2016","journal-title":"Acta Trop."},{"issue":"10","key":"10.1016\/j.biopha.2018.09.149_bib0205","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1468-3083.2011.04266.x","article-title":"Chronic cutaneous leishmaniasis, a great mimicker with various clinical presentations: 12 years experience from Aleppo","volume":"26","author":"Douba","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"6","key":"10.1016\/j.biopha.2018.09.149_bib0210","first-page":"458","article-title":"Erysipeloid leishmaniasis: an unusual clinical presentation","volume":"9","author":"Salmanpour","year":"1999","journal-title":"Eur. J. Dermatol."},{"issue":"10","key":"10.1016\/j.biopha.2018.09.149_bib0215","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-4362.2003.02015.x","article-title":"Rare variants of Cutaneous Leishmaniasis: whitlow, paronychia, and sporotrichoid","volume":"42","author":"Iftikhar","year":"2003","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0220","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4269\/ajtmh.2005.73.281","article-title":"Atypical clinical variants in New World cutaneous leishmaniasis: disseminated, erysipeloid, and recidiva cutis due to Leishmania (V.) panamensis","volume":"73","author":"Calvopina","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"12","key":"10.1016\/j.biopha.2018.09.149_bib0225","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1086\/345772","article-title":"Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil","volume":"186","author":"Turetz","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.149_bib0230","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/clinids\/21.3.663","article-title":"Atypical leishmaniasis in a patient infected with human immunodeficiency virus","volume":"21","author":"Mondain-Miton","year":"1995","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.149_bib0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4269\/ajtmh.2011.10-0398","article-title":"Atypical lesions as a sign of cutaneous dissemination of visceral leishmaniasis in a human immunodeficiency virus-positive patient simultaneously infected by two viscerotropic Leishmania species","volume":"85","author":"Santos-Oliveira","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.biopha.2018.09.149_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2018.03.004","article-title":"Identification of Leishmania (Viannia) species and clinical isolates of Leishmania (Leishmania) amazonensis from Brazil using PCR-RFLP of the heat-shock protein 70 gene reveals some unexpected observations","author":"Espada","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.149_bib0245","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/1040841X.2012.716818","article-title":"Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens?","volume":"39","author":"Vanaerschot","year":"2013","journal-title":"Crit. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.biopha.2018.09.149_bib0250","first-page":"1456","article-title":"Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis","volume":"13","author":"Borrell","year":"2009","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"8","key":"10.1016\/j.biopha.2018.09.149_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012211","article-title":"Linking in vitro and in vivo survival of clinical Leishmania donovani strains","volume":"5","author":"Vanaerschot","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biopha.2018.09.149_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023120","article-title":"Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden","volume":"6","author":"Vanaerschot","year":"2011","journal-title":"PLoS One"},{"issue":"13-14","key":"10.1016\/j.biopha.2018.09.149_bib0265","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijpara.2011.07.013","article-title":"Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells","volume":"41","author":"Mukhopadhyay","year":"2011","journal-title":"Int. J. Parasitol."},{"issue":"7","key":"10.1016\/j.biopha.2018.09.149_bib0270","doi-asserted-by":"crossref","first-page":"E575","DOI":"10.1073\/pnas.1213839110","article-title":"Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1","volume":"110","author":"Mukherjee","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.biopha.2018.09.149_bib0275","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2018.09.149_bib0280","doi-asserted-by":"crossref","first-page":"e2995","DOI":"10.1371\/journal.pntd.0002995","article-title":"Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-beta in early immune response","volume":"8","author":"Guha","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003476","article-title":"Intrachromosomal amplification, locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensis","volume":"9","author":"Monte-Neto","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2018.09.149_bib0290","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/AAC.49.8.3274-3280.2005","article-title":"Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana","volume":"49","author":"Al-Mohammed","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9185","key":"10.1016\/j.biopha.2018.09.149_bib0295","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2018.09.149_bib0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196247","article-title":"Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia","volume":"13","author":"Franco-Munoz","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2018.09.149_bib0305","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/cid\/civ004","article-title":"Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations","volume":"60","author":"Monge-Maillo","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"192","key":"10.1016\/j.biopha.2018.09.149_bib0310","first-page":"645","article-title":"The treatment of visceral leishmaniasis: safety and efficacy","volume":"52","author":"Jha","year":"2013","journal-title":"JNMA J. Nepal Med. Assoc."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.149_bib0315","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1038\/s41598-017-09720-1","article-title":"Miltefosine resistant field isolate from indian Kala-Azar patient shows similar phenotype in experimental infection","volume":"7","author":"Khanra","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.149_bib0320","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.09.149_bib0325","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jprot.2014.05.010","article-title":"Proteomic analysis of the soluble proteomes of miltefosine-sensitive and -resistant Leishmania infantum chagasi isolates obtained from Brazilian patients with different treatment outcomes","volume":"108","author":"Carnielli","year":"2014","journal-title":"J. Proteomics"},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0330","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/QCO.0b013e3283509cac","article-title":"Miltefosine and cutaneous leishmaniasis","volume":"25","author":"Machado","year":"2012","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0335","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"Soto","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"9","key":"10.1016\/j.biopha.2018.09.149_bib0340","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0345","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4269\/ajtmh.2010.10-0060","article-title":"Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis","volume":"83","author":"Velez","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.149_bib0350","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.41.4.827","article-title":"In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis","volume":"41","author":"Faraut-Gambarelli","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"24","key":"10.1016\/j.biopha.2018.09.149_bib0355","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.biopha.2018.09.149_bib0360","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1179\/136485906X118495","article-title":"Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia","volume":"100","author":"Bermudez","year":"2006","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"12","key":"10.1016\/j.biopha.2018.09.149_bib0365","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","article-title":"Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis","volume":"195","author":"Arevalo","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.149_bib0370","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biopha.2018.09.149_bib0375","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exppara.2016.05.003","article-title":"In vitro characterization of Leishmania (Viannia) braziliensis isolates from patients with different responses to Glucantime((R)) treatment from Northwest Parana, Brazil","volume":"167","author":"Fernandes","year":"2016","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.149_bib0380","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4269\/ajtmh.1992.47.117","article-title":"Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease","volume":"47","author":"Grogl","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.149_bib0385","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jac\/dkl494","article-title":"Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani","volume":"59","author":"Mukherjee","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2018.09.149_bib0390","first-page":"24","article-title":"Biophysical and pharmacological characterization of energy-dependent efflux of Sb in laboratory-selected resistant strains of Leishmania (Viannia) subgenus","volume":"5","author":"Dos Reis","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2018.09.149_bib0395","doi-asserted-by":"crossref","first-page":"e1167","DOI":"10.1371\/journal.pntd.0001167","article-title":"Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis","volume":"5","author":"Monte-Neto","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"15","key":"10.1016\/j.biopha.2018.09.149_bib0400","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1007\/s00216-013-6947-5","article-title":"Unexpectedly high levels of antimony (III) in the pentavalent antimonial drug Glucantime: insights from a new voltammetric approach","volume":"405","author":"Salaun","year":"2013","journal-title":"Anal. Bioanal. Chem."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218345013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218345013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:42:16Z","timestamp":1777272136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218345013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":80,"alternative-id":["S0753332218345013"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.149","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}